AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in Percent.
The item "Pretax-Margin" stands at 13.32 percent as of 09/30/2025.
As of the end of AstraZeneca PLC's third quarter, the item "Pretax Margin" stands at 13.32 Percent. This represents an increase of 2.10 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -2.13 compared to the value the year prior.
The Serie's long term average value is 10.13 percent. It's latest available value, on 09/30/2025, is 3.19 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +17.47 .
The Serie's change in percentage points from it's maximum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is -2.80.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Pretax Margin | 905,699,262,464.00 |
![]() | Johnson & Johnson - Pretax Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Pretax Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Pretax Margin | 317,433,206,677.55 |
![]() | Novartis AG - Pretax Margin | 255,096,620,580.91 |